Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

被引:19
作者
Wu, Feitong [1 ,2 ,3 ]
Juonala, Markus [4 ,5 ]
Jacobs Jr, David R. [6 ]
Daniels, Stephen R. [7 ]
Kahonen, Mika [8 ,9 ]
Woo, Jessica G. [10 ,11 ]
Sinaiko, Alan R. [12 ]
Viikari, Jorma S. A. [4 ,5 ]
Bazzano, Lydia A. [13 ]
Burns, Trudy L. [14 ]
Steinberger, Julia [15 ]
Urbina, Elaine M. [11 ,16 ]
Venn, Alison J. [1 ]
Raitakari, Olli T. [17 ,18 ,19 ,20 ,21 ]
Dwyer, Terence [1 ,22 ,23 ]
Magnussen, Costan G. [1 ,2 ,17 ,18 ,19 ]
机构
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Baker Dept Cardiometabol Hlth, Melbourne, Vic, Australia
[4] Univ Turku, Dept Med, Turku, Finland
[5] Turku Univ Hosp, Div Med, Turku, Finland
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland
[10] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
[11] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[12] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[13] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[14] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[15] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
[16] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[17] Univ Turku, Ctr Populat Hlth Res, Turku, Finland
[18] Turku Univ Hosp, Turku, Finland
[19] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[20] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland
[21] Univ Turku, InFLAMES Res Flagship, Turku, Finland
[22] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
[23] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会; 美国国家卫生研究院; 芬兰科学院; 欧洲研究理事会;
关键词
atherosclerosis; epidemiology; lipoproteins; longitudinal studies; risk assessment; risk factors; UNITED-STATES; HEART; EXERCISE; ADHERENCE; RISK; GUIDELINES; CHILDREN; OUTCOMES; UTILITY; YOUTH;
D O I
10.1161/CIRCULATIONAHA.123.064296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL- C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL- C levels with adult ASCVD events and determined whether non-HDL- C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL- C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL- C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]). CONCLUSIONS: Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [1] Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
    Vega, Gloria Lena
    Grundy, Scott M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 563 - 567
  • [2] Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
    Yun, Yeo-Min
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) : 221 - 222
  • [3] Determinants of Achieved LDL Cholesterol and "Non-HDL" Cholesterol in the Management of Dyslipidemias
    Packard, Chris J.
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (08)
  • [4] Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias
    Chris J. Packard
    Current Cardiology Reports, 2018, 20
  • [5] Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation
    Johannesen, Camilla Ditlev Lindhardt
    Mortensen, Martin Bodtker
    Nordestgaard, Borge Gronne
    Langsted, Anne
    ATHEROSCLEROSIS, 2025, 403
  • [6] Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
    Hansen, Malene Kaerslund
    Mortensen, Martin Bodtker
    Olesen, Kevin Kris Warnakula
    Thrane, Pernille Gro
    Maeng, Michael
    LANCET REGIONAL HEALTH-EUROPE, 2024, 36
  • [7] Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
    Carr, Stuart S.
    Hooper, Amanda J.
    Sullivan, David R.
    Burnett, John R.
    PATHOLOGY, 2019, 51 (02) : 148 - 154
  • [8] Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
    Shoar, Saeed
    Ikram, Waleed
    Shah, Ahmed Ali
    Farooq, Najam
    Gouni, Srikanth
    Khavandi, Soheila
    Tabibzadeh, Elsa
    Khavandi, Siamak
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (02) : 295 - 299
  • [9] Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort
    Carbayo Herencia, Julio A.
    Simarro Rueda, Marta
    Palazon Bru, Antonio
    Molina Escribano, Francisca
    Ponce Garcia, Isabel
    Artigao Rodenas, Luis Miguel
    Caldevilla Bernardo, David
    Divison Garrote, Juan A.
    Gil Guillen, Vicente Francisco
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2018, 30 (02): : 64 - 71
  • [10] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
    Boekholdt, S. Matthijs
    Arsenault, Benoit J.
    Mora, Samia
    Pedersen, Terje R.
    LaRosa, John C.
    Nestel, Paul J.
    Simes, R. John
    Durrington, Paul
    Hitman, Graham A.
    Welch, K. M. A.
    DeMicco, David A.
    Zwinderman, Aeilko H.
    Clearfield, Michael B.
    Downs, John R.
    Tonkin, Andrew M.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Kastelein, John J. P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12): : 1302 - 1309